![Derek Maetzold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek Maetzold
Gründer bei
CASTLE BIOSCIENCES, INC.
Vermögen: 5 Mio $ am 31.05.2026
Profil
Derek J.
Maetzold is the founder of Castle Biosciences, Inc., founded in 2007, where the title held is President, Chief Executive Officer & Director.
Current jobs include Director at AltheaDx, Inc. since 2021, Director at Prelude Corp.
since 2022, Director at Ocular Melanoma Foundation, and Director at IMPACT Melanoma, Inc. Former jobs include Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Education includes undergraduate studies at George Mason University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC. 0,84 % | 15.06.2026 | 253.861 ( 0,84 % ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Derek Maetzold
| Unternehmen | Position | Beginn |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Gründer | 01.09.2007 |
| ALTHEADX INC | Direktor/Vorstandsmitglied | 26.05.2021 |
Ocular Melanoma Foundation
 Ocular Melanoma Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable organization that provides eye cancer patient education and research funding services | Direktor/Vorstandsmitglied | - |
Prelude Corp.
 Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Direktor/Vorstandsmitglied | 02.02.2022 |
Ehemalige bekannte Positionen von Derek Maetzold
| Unternehmen | Position | Ende |
|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Vertrieb & Marketing | 01.05.2008 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.01.2003 |
Integrated Communications Corp.
 Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Creates ads for pharmaceutical companies | Corporate Officer/Principal | 01.01.1999 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direktor/Vorstandsmitglied | 01.01.1998 |
Sandoz Pharmaceuticals Corp. | Vertrieb & Marketing | 01.01.1996 |
Ausbildung von Derek Maetzold
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
AltheaDx, Inc.
 AltheaDx, Inc. Medical SpecialtiesHealth Technology Operates as a commercial stage molecular diagnostics company | Health Technology |
Integrated Communications Corp.
Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Creates ads for pharmaceutical companies | Commercial Services |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals Corp. | |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Health Technology |
Ocular Melanoma Foundation
Ocular Melanoma Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a charitable organization that provides eye cancer patient education and research funding services | Miscellaneous |
